Aids Therapy

Section I: Diagnosis of Hiv Infection. Establishing Diagnosis: Hiv Infection and Aids. Monitoring Patients with Hiv Infection. Section Ii: Antiretroviral Therapy. Zidovudine. Didanosine. Zalcitabine. Stavudine. Lamivudine. Nevaripine. Delavirdine. 1592. Loviride. Dmp-266. Saquinavir. Ritonavir. Indinavir. Nelfinavir. 141 W94 (Vx-478). Section Iii: Immune-Based Therapies. Immune-Based Therapies in the Management of Hiv-Infected Patients. Section Iv: Other Therapies, Including Alternative Therapies. Alternative Therapies. Section V: Strategies for Managing Antiretroviral Therapies. Managing Primary Infection. Postexposure Management. Initiation of Therapy. Maintaining Continued Benefit. Managing Pregnant Patients. Section Vi: Diagnosis, Therapy, And Prevention of Opportunistic Processes. Pneumocytosis. Toxoplasmosis. Cryptosporidiosis. Microsporidiosis. Enteric Bacterial Diseases. Myobacterium Tuberculosis. Myobacterium Avium Complex and Other Atypical Myobacterial Diseases. Bartonellosis. Cryptococcosis. Histoplasmosis. Coccidioidomycosis. Candidiasis. Mycosis Caused By Moulds. Cmv Disease. Varicella Zoster Virus Disease. Herpes Simplex Virus Infections. Epstein-Barr Virus Disease. Human Herpesvirus-6 and -7 Infection. Viral Hepatitis. Diseases Due to Respiratory Viruses. Sexually Transmitted Human Papillomavirus Infection. Jc Virus Neurologic Infection. Syphilis and Other Sexually Transmitted Diseases. Kaposi's Sarcoma. Non-Hodgkin's Lymphoma. Section Vii: Approach to Specific Syndromes. Wasting Syndrome. Neurologic Disease. Dermatologic Disease. Oropharyngeal Disease. Ophthalmologic Disease. Hematologic Disease. Cardiac Disease. Respiratory Disease. Renal Disease. Endocrine Disease. Gastrointestinal Disease. Hepatic and Hepatobiliary Disease. Section Viii: Drug Administration and Interactions. Drug Administration and Interactions. Appendix of Aids-Related Medications. Appendices: Phs Retroviral Guidelines. International Aids Guidelines. Postexposure Guidelines. Phs Oi Guidelines. Phs Std Guidelines